The Relationship Between Respiratory Function Tests and Serum Leptin IL-4, IL-10, IFN-ã Levels and Plasma Nitric Oxide Concentrations in Asthmatic Adults

Yıl 2013, Cilt: 14 Sayı: 1, 23 - 30, 01.04.2013

Mustafa Yılmaz Mustafa Altınışık Mehmet Polatlı Nimet Demirtaş Cengiz Gökbulut Orhan Çildağ

Öz

PURPOSE: Asthma is accepted as a chronic inflammatory disease of the airway epithelium. In asthma, balance between Th1/Th2 lymphocytes is changed in favour of the Th2 lymphocytes. In this study, it was aimed to investigate the relationship between respiratory function tests and serum leptin, IL-4, IL-10, IFN-γ levels and plasma nitric oxide concentrations. MATERIAL and METHODS: In this study, 32 clinically asthma diagnosed patients were taken as a patient group and 32 healthy individuals as a control group. Respiratory function tests for each case were carried out with spirometer. Serum leptin, IL-4, IL-10, and IFN-γ levels were measured with a commercial kit that uses ELISA. Plasma nitrite and nitrate levels were detected with HPLC. Data were analysed with, Student t-test and Pearson correlation test by using SPSS 13.0 software. RESULTS: In control group, there was a positive correlation between leptin levels and FEV1 and FVC with the value of r=0,443 p=0,005 and r=0,440 p=0,013 respectively, whereas in patient group, there was a negative correlation between leptin levels and FEV1 with the value of r=-0,366 p=0,043. Serum leptin levels were significantly higher in women compared to men, p<0,001. In patient group, plasma nitric oxide levels were significantly lower compared to the control group, p=0,012. CONCLUSION: These findings suggest that, airway inflammation may have systemic effects in asthma so that leptin and nitric oxide levels might be useful parameters to detect these systemic effects.

Anahtar Kelimeler

Asthma, leptin, nitrik oksit, IL-4, IL-10, IFN-ã

Kaynakça

• McDowell KM. Pathophysiology of asthma. Respir Care Clin N Am 2000;6(1):15-26. 2.
• Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese g e n e a n d i t s h u m a n h o m o l o g u e . N a t u r e 1994;372(6505):425-32.
• Mantzoros CS. The role of leptin in human obesity and disease: A review of current evidence. Ann Intern Med 1999;130:671-80.
• Beltowski J, Wojcicka G, Jamroz A. Stimulatory effect of leptin on nitric oxide production is impaired in dietary-induced obesity. Obes Res 2003;11(12): 1571- 80.
• Barnes PJ. Nitric oxide and airway disease. Ann Med 1995;27(3): 389-93.
• Moshage H, Kok B, Huizenga JR, Jansen PL. Nitrite and nitrate determinations in plasma: a critical evaluation. Clin Chem 1995;41:892-6.
• Mai XM, Böttcher MF, Leijon I. Leptin and asthma in overweight children at 12 years of age. Pediatr Allergy Immunol 2004;15: 523-30.
• Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;373(5789):373- 6
• MaffeiM, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNAin obese and weight-reduced subjects. Nature Med1995;1:1155-61. 3.
• Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive leptin concentrations in normal- weight and obese humans. N Engl J Med 4. 1996;334:292-5.
• Blum WF, Englaro P, Hanitsch S, et al. Plasma leptin levels in healthy children and adolescents: dependence on body mass index, body fatmass, gender, pubertal 5.
• stage and testosterone. J Clin Endocrinol Metab 1997;82:2904-10. 6.
• Mai XM, Böttcher MF, Leijon I. Leptin and asthma in overweight children at 12 years of age. Pediatr Allergy Immunol 2004;15: 523-30. 7.
• Shimizu H, Shimomura Y, Hayashi R, ve ark. Serum leptin concentration is associated with total body fat mass, but not abdominal fat distribution. Int J Obes 8. 1997;21:536-41.
• Sin DD, Man SFP. Impaired lung function and serum leptin in men and women with normal body weight: a population based study. Thorax 2003;58:695-8. 9.
• Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327(6122):524-6.
• Güler N, Kirerleri E, Ones Ü, et al. Leptin: Does it have any role in childhood asthma? J Allergy Clin Immunol 2004;114:254-9.
• Kýrkýl G, Deveci F, Muz MH, Ýlhan F, Çakýr Y. Serum 10. Alving K, Weitzberg E, Lundberg JM. Increased leptin levels in stable asthmatic patients and relation between leptin and severity of asthma, and obesity, Solunum 2006;8:27-32.
• patients. Eur Respir J 1993; 6: 268-70.
• Pawankar R, Okuda M, Yssel H, Okumura K, Ra C: 28. Borish L, Aarons A, Rumbyrt J, Cvietusa P, Negri J, Nasal mast cells in perennial allergic rhinitis exhibit increased expression of the Fc epsilon RI, CD40L, IL- 4, and IL-13, and can induce IgE synthesis in B cells. J Clin Invest 1997, 99:1492-9.
• Wenzel S. Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol 1996; 97:1288-96.
• Moore KW, Malefyt RW. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001;19:683-765.
• Tang ML, Coleman J, Kemp AS. Interleukin-4 and interferon- gamma production in atopic and non-atopic children with asthma. Clin Exp Allergy 1995;25:515- 21.
• Matsumoto T, Miike T, Yamaguchi K, Murakami M. Kawabe T, Yodoi J. Serum levels of soluble IL-2 receptor, IL-4 and IgE-binding factors in childhood allergic diseases. Clin Exp Immunol 1991;85:288-92.
• Corrigan CJ, Kay AB. CD4 T-lymphocyte activation in acute severe Asthma.Relationship to disease severity and atopic status. Am Rev Respir Dis 1990;141:970-7.
• Saito H, Hayakawa T, Mita H, Yui YS, Shida T. Augmentation of leukotriene C4 production by gamma interferon in leukocytes challenged with an allergen. Int Arch Allergy Appl Immunol 1988;87:286-93.
• Hashimoto S, Amemiya E, Tomita Y, et al. Elevation of soluble IL-2 receptor and IL-4, and nonelevation of IFN-gamma in sera from patients with allergic asthma. Ann Allergy 1993;71:455-8.
• Tang ML, Coleman J, Kemp AS. Interleukin-4 and interferon-gamma production in atopic and non-atopic children with asthma. Clin Exp Allergy 1995;25:515-2. 36. Ying S, Durham SR, Corrigan CJB, Hamid Q, Kay AB. Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon-ã) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal subjects. Am J Respir Cell Mol Biol 1995; 12: 477-87.
• Çalýkoðlu M, Ünlü A, Ulubaþ B, Ercan B, Çimen B,Tamer L, Kanýk A. Hafif astýmlý hastalarda serum nitrik oksit ve 3-nitrotirozin düzeyleri. Allerji Astým Dergisi 2001;3:126-30.
• Oðuzülgen Ý, Türktaþ H, Erbaþ D. Stabil astýmda ekspirasyon havasýndaki nitrik oksit düzeyini etkileyen faktörler. Türk Toraks Dergisi 2002;3:232-35.
• Yurdakul AS, Canbakan S, Çapan N, Baþer Y. Bronþiyal astýmlý hastalarda ekspire edilen havadaki nitrik oksit düzeyi. Solunum Hastalýklarý 2006;17:105-10.
• Sanders SP. Nitric oxide in asthma. Am J Respir Cell Mol Biol 1999;21:147-9. YAZIÞMA ADRESÝ
• Uzm. Dr. Mustafa YILMAZ
• Yýl Milas Devlet Hastanesi, Biyokimya
• Laboratuvarý, MUÐLA, TÜRKÝYE E-Posta
• : [e-mail] Geliþ Tarihi Kabul Tarihi : 09.01.2013